Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,578 | -5,298 | -4,780 | N/A | -7,698 |
| Depreciation Amortization | 669 | 525 | 520 | N/A | 524 |
| Accounts payable and accrued liabilities | 513 | 49 | N/A | N/A | N/A |
| Other Working Capital | 8,070 | -200 | -120 | N/A | 337 |
| Other Operating Activity | -852 | 6 | 190 | 0 | 16 |
| Operating Cash Flow | $-3,178 | $-4,918 | $-4,190 | $N/A | $-6,821 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,289 | -46,715 | N/A | N/A | N/A |
| PPE Investments | -2,723 | -897 | -370 | N/A | -292 |
| Purchase Sale Intangibles | -102 | -101 | N/A | N/A | N/A |
| Other Investing Activity | -102 | -101 | 6,170 | 0 | -26,870 |
| Investing Cash Flow | $1,464 | $-47,713 | $5,800 | $N/A | $-27,162 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -12 | -13 | N/A | N/A | N/A |
| Common Stock Issued | 1,551 | 48,964 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 6,940 | 0 | 31,484 |
| Financing Cash Flow | $1,538 | $48,951 | $6,940 | $N/A | $31,484 |
| Beginning Cash Position | 8,631 | 12,311 | 3,750 | N/A | 6,135 |
| End Cash Position | 8,456 | 8,631 | 12,310 | N/A | 3,636 |
| Net Cash Flow | $-176 | $-3,680 | $8,550 | $N/A | $-2,499 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,178 | -4,918 | -4,190 | N/A | -6,821 |
| Capital Expenditure | -2,723 | -897 | N/A | N/A | N/A |
| Free Cash Flow | -5,901 | -5,815 | -4,190 | 0 | -6,821 |